• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后第 1 天血浆纤维蛋白原水平与 HBV 相关 HCC 患者行原位肝移植 2 年生存率的相关性研究。

Association of Plasma Fibrinogen Levels on Postoperative Day 1 with 2-Year Survival of Orthotopic Liver Transplantation for HBV-Related HCC.

机构信息

Department of Intensive Care Unit, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Department of Laboratory Medicine, First Affiliated Hospital, College of Medicine, Zhejiang University, Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Hangzhou, Zhejiang, China.

出版信息

Lab Med. 2022 Jan 6;53(1):30-38. doi: 10.1093/labmed/lmab052.

DOI:10.1093/labmed/lmab052
PMID:34268570
Abstract

OBJECTIVE

To clarify the prognostic values of hemostatic parameters to predict the survival of patients undergoing orthotopic liver transplantation (OLT) for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

METHODS

The data of 182 consecutive adult patients who underwent OLT for HBV-related HCC were subjected to univariate and multivariate analyses.

RESULTS

Ascites and fibrinogen levels on postoperative day (POD) 1 were independent predictors of postoperative 2-year mortality (both P <.05). Kaplan-Meier survival analysis showed that the higher the fibrinogen level on POD 1, the better the 1- and 2-year survival of patients with ascites (P <.05), whereas the fibrinogen level on POD 1 was associated with 1-year (P <.05) but not 2-year survival of patients without ascites.

CONCLUSION

Fibrinogen on POD 1 is a predictor of 2-year post-OLT survival of patients with HBV-related HCC with ascites.

摘要

目的

阐明止血参数对预测乙型肝炎病毒(HBV)相关肝细胞癌(HCC)患者行原位肝移植(OLT)后生存情况的预后价值。

方法

对 182 例连续接受 OLT 治疗的 HBV 相关 HCC 成年患者的数据进行单因素和多因素分析。

结果

术后第 1 天的腹水和纤维蛋白原水平是术后 2 年死亡率的独立预测因素(均 P<.05)。Kaplan-Meier 生存分析显示,腹水患者第 1 天的纤维蛋白原水平越高,1 年和 2 年的生存率越高(P<.05),而第 1 天的纤维蛋白原水平与无腹水患者的 1 年生存率相关(P<.05),但与 2 年生存率无关。

结论

第 1 天的纤维蛋白原是伴有腹水的 HBV 相关 HCC 患者 OLT 后 2 年生存的预测因子。

相似文献

1
Association of Plasma Fibrinogen Levels on Postoperative Day 1 with 2-Year Survival of Orthotopic Liver Transplantation for HBV-Related HCC.术后第 1 天血浆纤维蛋白原水平与 HBV 相关 HCC 患者行原位肝移植 2 年生存率的相关性研究。
Lab Med. 2022 Jan 6;53(1):30-38. doi: 10.1093/labmed/lmab052.
2
Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.肝移植后乙型肝炎表面抗原阳性患者的肝细胞癌复发和乙型肝炎再感染。
Liver Transpl. 2009 Nov;15(11):1525-34. doi: 10.1002/lt.21882.
3
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.肝细胞癌与肝移植后乙型肝炎病毒复发风险增加相关。
Gastroenterology. 2008 Jun;134(7):1890-9; quiz 2155. doi: 10.1053/j.gastro.2008.02.064. Epub 2008 Mar 4.
4
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.伴有和不伴有肝细胞癌的慢性乙型肝炎肝移植候选者的临床结局比较。
Liver Transpl. 2007 Mar;13(3):334-42. doi: 10.1002/lt.20959.
5
Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation.肝移植患者中乙型肝炎与肝细胞癌复发之间的关联。
Transplant Proc. 2008 Jun;40(5):1511-7. doi: 10.1016/j.transproceed.2008.03.156.
6
Prognosis in liver transplantation recipients after hepatitis B virus recurrence.乙型肝炎病毒复发后肝移植受者的预后
Hepatogastroenterology. 2014 Oct;61(135):2047-51.
7
α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.甲胎蛋白是入选肝移植的乙型肝炎相关肝细胞癌患者的潜在生存预测指标。
Eur J Gastroenterol Hepatol. 2014 May;26(5):544-52. doi: 10.1097/MEG.0000000000000029.
8
Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.乙型肝炎病毒相关肝细胞癌患者的肝移植:病毒特征对临床结果的影响。
Ann Surg Oncol. 2013 Oct;20(11):3582-90. doi: 10.1245/s10434-013-3023-5. Epub 2013 Jun 13.
9
Liver Transplantation for Hepatocellular Carcinoma in Young Adults: A United Network for Organ Sharing Study.青年成人肝细胞癌的肝移植:器官共享联合网络研究
J Adolesc Young Adult Oncol. 2017 Jun;6(2):286-293. doi: 10.1089/jayao.2016.0048. Epub 2016 Dec 20.
10
Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.1999 年至 2010 年中国乙型肝炎或丙型肝炎相关肝细胞癌肝移植受者的生存状况。
PLoS One. 2013 Apr 16;8(4):e61620. doi: 10.1371/journal.pone.0061620. Print 2013.

引用本文的文献

1
Reoperation etiologies in the initial hospital stay after liver transplantation: a single-center study from Iran.肝移植术后首次住院期间再次手术的病因:来自伊朗的一项单中心研究。
Korean J Transplant. 2023 Jun 30;37(2):103-108. doi: 10.4285/kjt.23.0026.